Analysis Is biotech facing a long bear market? As news of layoffs and downsizing across a handful of biotechs continues to come in, the sector may not be out of the woods just yet By Adam Zamecnik
Analysis Neglected tropical diseases: non-profits lead the way as private sectors lags By Adam Zamecnik
Analysis From a race to a crawl: How delays derailed Covid-19 vaccination in Africa By Andrew Hillman
Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years In the first edition of Pharmaceutical Technology’s series on the FDA’s orphan drug program, we examine how its popularity has… а> By Irena Maragkou
Analysis The opioid epidemic: is pharma doing enough to develop treatments for the crisis? By Adam Zamecnik
Analysis Tracking the rise of CAR-Ts in China: the dawn of an immunotherapy superpower? By Andrew Hillman and Manasi Vaidya
Analysis Can Relmada’s fast-acting pill for major depressive disorder compete in a crowded market? By William Newton
Ultra-Quiet, Super-Light Temperature Control Unit for Research Laboratories By Huber Kältemaschinenbau
Comment Russia’s focus on domestic pharma production could shield it from sanctions’ effects By GlobalData Healthcare
Comment Non-stop investment from CMOs and US Government into continuous manufacturing By GlobalData Healthcare
Cloud hiring levels in the pharmaceutical industry rose in June 2022 We've analysed hiring patterns using data from GlobalData а> By Data Journalism Team
Analysis Machine learning hiring levels in the pharmaceutical industry rose in May 2022 By Data Journalism Team
Analysis Cloud hiring levels in the pharmaceutical industry rose in April 2022 By Data Journalism Team
Electronic Health Records (EHRs) – Analyzing Trends, Technologies, Physicians’ Adoption and Perceptions, Use Barriers and Opportunities, and Future Prospects 1495
Waldenstrom Macroglobulinemia (WM) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape 3495